drugset / Trial / NCT00286013

Feasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal Cholangiocarcinoma

NCT00286013 ↗

Phase 2 Completed 24 enrolled University Hospital, Ghent
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The aim of the study is to evaluate the feasibility defined as overall tolerance and toxicity as well as relative dose-intensity and cumulative dose delivered, of an association ofgemcitabine, oxaliplatin and radiotherapy in patients with locally advanced and unresectable, but non-metastatic pancreatic adenocarcinoma or cholangiocarcinoma

Timeline

Start
2004-05-01
Primary completion
2006-05-31
Completion
2008-07-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule — —
Subject Oxaliplatin Small molecule — —